Only a few vaccines - for example, against polio and rotavirus - can be given orally. Most must be delivered by injection. Researchers suggest this may be, in part, because the training program of the immune cells in the gut takes place under harsh conditions. They investigated this process for the gut-based cells involved in long-term immunity using a novel imaging method that captures all of the immune cells' niches within a single organ. Their findings provide new insights that may, in the future, lead to the design of more effective oral vaccines.
The effective, long-lasting protection we expect from a vaccine originates in a response that is undertaken by immune cells called B cells. Each of these immune cells secretes one antibody -molecules that bind a specific target. Following exposure to a vaccine or invading pathogen, a preparation program selects the B cells with the antibodies most fit to attack the particular threat, admitting them to special training niches within the lymph nodes. There, these cells undergo rounds of division and mutational changes until a pool of finely-honed, "high-affinity" antibody-producing cells is created; these cells persist in the body, providing immunity even to future challenges from this specific threat.
The lymphoid organs in the intestines, in addition to hosting B-cell training against pathogenic diseases, also keep the gut bacteria in check, making it difficult to discern each function separately. And the specialized immune niches within the organs are so small and well hidden, it is hard to study them with the standard methods. The authors developed a way to remove and image the gut lymph organ, borrowing the "clear brain" method from neurobiology in which tissue is made transparent and the organ then viewed with standard light sheet fluorescence microscopy. This method enabled them to capture all of the immune niches in an entire organ and to study how these compartments contribute to the emerging immune response. The researchers then analyzed the gut lymphoid organs from mice that had been immunized orally.
"We found that the lymph organs in the gut operate by a different set of rules than those in the peripheral lymph system," says the author. In fact, the gut lymph system does not collect antigens through tissue drainage, as happens in the peripheral lymph nodes, but rather by active uptake of vaccine or pathogen particles from inside the gut. And if the peripheral system is a "capitalist" one that aims to select and produce the most effective antibodies quickly, the gut system works on a more socialistic principle, at least in the beginning. That is, cell producing antibodies with any level of affinity, at all, are allowed to divide and secrete antibodies in response to the threat during the early response. Only later do some with higher affinity gain admittance to the training grounds for further improvement.
Next, the group used their method to observe the gut lymph-based B cells together with "trainer" cells that select the high-affinity variants. They found that these cells physically interact with the B cells within small niches just as they do in the peripheral lymph nodes. In other words, the "training manual" was there and opened to the right page. Unlike in the peripheral lymph nodes, however, the trainers in the gut seemed to lack a crucial piece of information: They were unable to distinguish between high- and low-affinity antibodies.
This limitation, the researchers thought, might lie in the complex environment in which the lymph organs operate: They are exposed to immense amounts of antigens from the ever-present gut bacteria. Within this setting, the antigens delivered in a vaccine would be lost in the crowd, diluted to the point it would be impossible to select B cells based on antibody affinity. When the researchers artificially increased the antigen in the mouse gut, they were able to reactivate the trainer-cell program for selecting the fittest B cells.
"The antibody response in the gut takes place in two stages. The first is an all-out 'do the best we can with what we have' reaction. At this stage, affinity-based selection is delayed, and both low- and high-affinity antibodies are produced. For the second phase, the immune cells must make it into niches in which the proper antigens have accumulated over time, so that affinity training can take place. As opposed to the peripheral lymph system, the antigen levels within the gut's immune cell niches are mostly too low to stimulate efficient antibody generation," says the author.
Researchers say that further research into the rules controlling the gut lymphoid organs could lead to new ways of targeting antigens and recruiting B cells into the affinity training programs, thus enabling the development of new or improved oral vaccines.
https://wis-wander.weizmann.ac.il/life-sciences/revealing-gut%E2%80%99s-b-cell-training-program-may-point-new-means-developing-oral-vaccines
https://www.nature.com/articles/s41590-019-0325-1
Gut immune cells operate differently
- 1,041 views
- Added
Edited
Latest News
Therapeutic avenues in bone…
By newseditor
Posted 23 May
Linking key nutrients with…
By newseditor
Posted 23 May
Ferroptosis in fatal COVID-…
By newseditor
Posted 22 May
Grid cell-like representati…
By newseditor
Posted 22 May
Cellular mechanisms underly…
By newseditor
Posted 22 May
Other Top Stories
A key protein linked to ageing identified
Read more
Vasomotion is critical in clearing amyloid from the brain
Read more
Using health records and not genetic data to calculate genetic link…
Read more
Tau and amyloid team up to damage synapses!
Read more
Neurons regulating early alcohol consumption identified!
Read more
Protocols
Efficient expansion and CRI…
By newseditor
Posted 21 May
Massively parallel in vivo…
By newseditor
Posted 20 May
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Methods for making and obse…
By newseditor
Posted 15 May
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Publications
Therapeutic avenues in bone…
By newseditor
Posted 23 May
Investigating nutrient biom…
By newseditor
Posted 23 May
Fatal COVID-19 pulmonary di…
By newseditor
Posted 22 May
GABA co-released from stria…
By newseditor
Posted 22 May
The IL-33/ST2 axis is prote…
By newseditor
Posted 22 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar